ABOUT
What you missed at: 2nd Oligonucleotides CMC & Analytical Development Summit 2023
The 2nd Oligonucleotides CMC & Analytical Development Summit returned this August to Boston. 70+ industry leaders united at this unique forum dedicated to CMC and Analytical Experts.
Across 3 days, senior leaders leveraged knowledge and shared thought-leadership focused on improving analytical characterization, effectively preparing CMC data for IND filing and scaling up with long-term manufacturing in mind.
Built with experts from AstraZeneca, Alexion Pharmaceuticals, Biogen, drug development protocols were revolutionized by keeping our finger on the pulse at this hotly anticipated summit.
Explored analytical control strategies for therapeutic oligonucleotides to ensure safety and quality with regulatory compliance
Overcame the challenges of capacity when out-sourcing to propel and expedite oligonucleotide development
Got interactive in roundtable discussions, picking the brains of your peers and expert speakers on how biopharma is currently navigating the regulatory landscape
Facilitated cost-efficient large-scale production of oligonucleotides now we are moving into larger patient populations and non-rare disease indications
Turbocharged novel and complex oligonucleotide development in an in-depth workshop outlining CMC, Analytical Characterization and Impurity Control of conjugates